0001818399-20-000002.txt : 20200722 0001818399-20-000002.hdr.sgml : 20200722 20200721184532 ACCESSION NUMBER: 0001818399-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200722 DATE AS OF CHANGE: 20200721 EFFECTIVENESS DATE: 20200722 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nanoscope Therapeutics, Inc. CENTRAL INDEX KEY: 0001818399 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-371542 FILM NUMBER: 201039817 BUSINESS ADDRESS: STREET 1: 1312 BROWN TRAIL STREET 2: SUITE A CITY: BEDFORD STATE: TX ZIP: 76022 BUSINESS PHONE: 817.719.2692 MAIL ADDRESS: STREET 1: 1312 BROWN TRAIL STREET 2: SUITE A CITY: BEDFORD STATE: TX ZIP: 76022 D 1 primary_doc.xml X0708 D LIVE 0001818399 Nanoscope Therapeutics, Inc. 1312 BROWN TRAIL SUITE A BEDFORD TX TEXAS 76022 817.719.2692 DELAWARE None None Corporation true 2017 Sulagna Bhattacharya 1312 Brown Trail Suite A Bedford TX TEXAS 76011 Executive Officer Director Samarendra Mohanty 1312 Brown Trail Suite A Bedford TX TEXAS 76011 Executive Officer Director Alvaro Guillem 800 West Jeter Road Bartonville TX TEXAS 76226 Director Other Health Care Decline to Disclose 06b false 2020-07-08 false true false 0 16069786 12799974 3269812 false 12 0 0 0 false Nanoscope Therapeutics, Inc. Sulagna Bhattacharya Sulagna Bhattacharya Secretary and Chief Executive Officer 2020-07-21